Tubulointerstitial inflammation driving interstitial fibrosis and tubular atrophy predicts poor renal outcome in refractory lupus nephritis

Systemic Lupus Erythematosus

Long-term renal outcomes, cardio-vascular events and severe infections in patients with lupus nephritis: MassiLUP cohort 2001-2022

Rheumatology (Oxford)

Goupille B, Resseguier N, Torrents J, Bataille S, Beaume J, Bobot M, Brunet P, Burtey S, Corthier A, Faraut J, Sallee M, Chiche L, Daniel L, Jourde-Chiche N

doi: 10.1093/rheumatology/keaf532

Systemic Lupus Erythematosus

Comparison of predictive validity of the Lupus Patient-Reported Outcome and Short-Form-12 for damage accrual in systemic lupus erythematosus

Rheumatology (Oxford)

Onishi A, Tsuji H, Sasai T, Shirakashi M, Hiwa R, Nakabo S, Akizuki S, Nakashima R, Nishimura K, Sada KE, Miyawaki Y, Umeda M, Yoshimi R, Ohno S, Yajima N, Kajiyama H, Sato S, Kishida D, Fujiwara M, Kida T, Matsuo Y, Takatani A, Onishi T, Ida T, Umekita K, Miyake H, Nakano H, Ikeda K, Ichinose K, Yoshifuji H, Tanaka M, Morinobu A

doi: 10.1093/rheumatology/keag080

Further Publications Immunology

Daratumumab monotherapy reverses the immune and pro-fibrotic profiles in refractory lupus nephritis patients: a pilot case study

J Autoimmun

Roccatello D, Barinotti A, Radin M, Cecchi I, Rubini E, Mancardi D, Cozzi M, Fenoglio R, Sciascia S

doi: 10.1016/j.jaut.2025.103520

Systemic Lupus Erythematosus

Prevalence and outcomes of a pilot definition of severe refractory systemic lupus erythematosus: observations from a multinational Asia-Pacific cohort

Arthritis Res Ther

Kandane-Rathnayake R, Louthrenoo W, Lau CS, Hamijoyo L, Cho J, Lateef A, Luo SF, Wu YJ, Navarra S, Zamora L, Li Z, Chen YH, Oon S, Chan M, Sockalingam S, Hao Y, Zhang Z, Bae SC, Kikuchi J, Takeuchi T, Katsumata Y, Basnayake B, Goldblatt F, O'Neill S, Pek Ling Ng K, Tugnet N, Sapsford M, Poh YJ, Tee C, Tee M, Ohkubo N, Lefeber AO, Shisha T, Tanaka Y, Golder V, Nikpour M, Hoi A, Gergely P, Morand E

doi: 10.1186/s13075-025-03622-8

Systemic Lupus Erythematosus

Predictors and long-term impact of sustained complete renal response in lupus nephritis patients over a median 10-year follow-up

Rheumatology (Oxford)

Michelakis IE, Kapsia E, Boletis JN, Marinaki S, Sfikakis PP, Tektonidou MG

doi: 10.1093/rheumatology/keaf677

Systemic Lupus Erythematosus

Systemic lupus erythematosus-disease activity score remission and low disease activity were similarly associated with patient-reported outcomes compared with definition of remission in systemic lupus erythematosus remission and lupus low disease activity state

Rheumatology (Oxford)

Nakanishi E, Matsushita M, Minowa K, Tada K, Kawamoto T, Kusaoi M, Amano H, Kon T, Morimoto S, Ikeda K, Suzuki S, Nozawa K, Yang KS, Matsudaira R, Katagiri A, Tsushima H, Urasaki W, Nojiri S, Yamaji K, Tamura N

doi: 10.1093/rheumatology/keaf349

Autoimmune Disease

Systemic lupus international collaborating clinics frailty index (SLICC-FI) predicts worsening health-related quality of life, data from the almenara lupus cohort

Arthritis Care Res (Hoboken)

Singh A, Gamboa-Cárdenas RV, Pimentel-Quiroz V, Rodriguez-Bellido Z, Pastor-Asurza C, Perich-Campos R, Alarcón GS, Ugarte-Gil MF

doi: 10.1002/acr.25544

Systemic Lupus Erythematosus

Implementation outcomes of a patient decision-aid in a diverse population with systemic lupus erythematosus in 15 U.S. rheumatology clinics

Rheumatology (Oxford)

Singh JA, Hearld LR, Eisen S, Chatham WW, Narain S, Annapureddy N, Kamen DL, Trotter K, Majithia V, Lee Ching C, Aouhab Z, Venuturupalli S, Wallace DJ, Ramsey-Goldman R, Kim A, McMahon M, Sam Lim S, Bhairavarasu K, Meara A, Kalunian K, Beasley M, Implementing DEcision-Aid for Lupus in clinics (IDEAL) Consortium

doi: 10.1093/rheumatology/keaf205

Further Publications Rheumatology

2024 American College of Rheumatology (ACR) Guideline for the Screening, Treatment, and Management of Lupus Nephritis

Arthritis Rheumatol

Sammaritano LR, Askanase A, Bermas BL, Dall'Era M, Duarte-García A, Hiraki LT, Rovin BH, Son MBF, Alvarado A, Aranow C, Barnado A, Broder A, Brunner HI, Chowdhary V, Contreras G, Felix C, Ferucci ED, Gibson KL, Hersh AO, Izmirly PM, Kalunian K, Kamen D, Rollins B, Smith BJ, Thomas A, Timlin H, Wallace DJ, Ward M, Azzam M, Bartels CM, Cunha JS, DeQuattro K, Fava A, Figueroa-Parra G, Garg S, Greco J, Cuéllar-Gutiérrez MC, Iyer P, Johannemann AS, Jorge A, Kasturi S, Kawtharany H, Khawandi J, Kirou KA, Legge A, Liang KV, Lockwood MM, Sanchez-Rodriguez A, Turgunbaev M, Williams JN, Turner AS, Mustafa RA

doi: 10.1002/art.43212

Related content

Long-term renal outcomes, cardio-vascular events and severe infections in patients with lupus nephritis: MassiLUP cohort 2001-2022

Comparison of predictive validity of the Lupus Patient-Reported Outcome and Short-Form-12 for damage accrual in systemic lupus erythematosus

Daratumumab monotherapy reverses the immune and pro-fibrotic profiles in refractory lupus nephritis patients: a pilot case study

Prevalence and outcomes of a pilot definition of severe refractory systemic lupus erythematosus: observations from a multinational Asia-Pacific cohort

Predictors and long-term impact of sustained complete renal response in lupus nephritis patients over a median 10-year follow-up

Systemic lupus erythematosus-disease activity score remission and low disease activity were similarly associated with patient-reported outcomes compared with definition of remission in systemic lupus erythematosus remission and lupus low disease activity state

Systemic lupus international collaborating clinics frailty index (SLICC-FI) predicts worsening health-related quality of life, data from the almenara lupus cohort

Implementation outcomes of a patient decision-aid in a diverse population with systemic lupus erythematosus in 15 U.S. rheumatology clinics

2024 American College of Rheumatology (ACR) Guideline for the Screening, Treatment, and Management of Lupus Nephritis